Showing results for: "shield clinical" (61 results)
Explore the multi-organ cellular mapping of GLP-1 receptor agonists. Discover how GLP-1RAs act as a systemic shield across T2DM, obesity, PMOS, MASH and so on.
This article aims to demystify the anatomy of a clinical trial protocol, peeling back the technical layers to reveal how scientific rigor is converted into medical progress. At ScientistsHub, we often ask: How do we ensure that a medical breakthrough is not just a stroke of luck, but a repeatable, verifiable victory for human health? The answer is found in the design. To truly appreciate the result of any trial, one must first master the architecture of the inquiry.
This article will unlock that box, exploring the crucial process of translating complex clinical trial evidence into clear, understandable information for everyone. We'll journey from the surprising origins of clinical trials to the modern-day push for transparency, and discover why making science accessible is not just a convenience, but a necessity for public trust and informed health decisions.
(DCTs) are redefining how pharmaceutical studies are designed, conducted, and analyzed by moving away from traditional site-centric models toward patient-centric, digitally enabled trial ecosystems.
Artificial Intelligence AI with it’s widespread use in various sectors has also taken a dive into healthcare by transforming clinical practice and improving patient care.
Disorders of Gut–Brain Interaction (DGBIs), such as Functional Dyspepsia (FD) and Irritable Bowel Syndrome (IBS), present a formidable clinical impasse due to their profoundly heterogeneous and multifactorial nature.
This architecture is essential for shielding neurons from toxins, pathogens, and fluctuations in the bloodstream, but it also creates a devastating bottleneck for modern medicine. More than 98% of small-molecule drugs and nearly all large biological therapeutics fail to cross the BBB in meaningful amounts, leaving many promising treatments for neurodegenerative disorders, brain tumors, and inflammatory diseases stranded in the circulation.
With the potential of AI tools revolutionizing the world of healthcare, there are ethical risk factors that need to be looked at before their implementation.
Artificial Intelligence(AI) is reshaping the future of healthcare. The US and UK healthcare systems started to adopt tools like AI Scribe and conversational chatbots, as they claimed to outperform clinicians in diagnostics. Survey data from over 100 physicians polled by Fierce Healthcare and Sermo indicate that many doctors are using general-purpose LLMs for clinical tasks.
Inhalable vaccines trigger powerful mucosal immunity where pathogens enter the body, offering needle-free protection against respiratory diseases.
Stem cell therapy research is a promising area of interest for a number of scientists working to understand Parkinson’s disease and develop treatments for it. Read below to learn more about the advancements of stem cell therapy for Parkinson’s.
Can algorithms predict sickness before you feel it? Explore how AI is using smartwatch data and ECGs to detect diseases like Alzheimer's and AFib early.
The tumor microenvironment (TME) is a complex and dynamic ecosystem composed of malignant cells, immune infiltrates, stromal elements, and vascular components that collectively influence tumor initiation, progression, immune escape, and therapeutic response. Traditional bulk transcriptomic approaches obscure this complexity by averaging gene expression across heterogeneous cell populations.
Bacterial lysates and postbiotics can train your immune system to prevent respiratory infections. Here is why they matter in the era of antibiotic resistance.
The current trajectory of epilepsy management has encountered a formidable "refractory wall." Despite the accelerated expansion of the neuropharmacological pharmacopeia,
Discover what Polycystic Ovary Syndrome is. Its causes, symptoms, and diagnosis. A clear, research-based guide to this common hormonal disorder.
Injury is an inherent risk of sport participation. Whether at elite or recreational level, athletes are exposed to physical loads that challenge tissue capacity and recovery.
A Full Blood Count (FBC) is a blood test that measures different types of blood cells and related parameters, including red blood cells, white blood cells, platelets, haemoglobin, haematocrit and red blood cell indices. It can help healthcare professionals investigate conditions such as anaemia, infection, inflammation and certain blood disorders.
Biologics have transformed the management of chronic and life-threatening diseases such as cancer, autoimmune disorders, and metabolic conditions. However, their complexity, high production costs, and limited affordability continue to challenge healthcare systems worldwide.
Today, generalized anxiety disorder is affecting millions of Americans. The disorder usually traps the sufferers in cycles of fear and isolation in a way that even standard treatments cannot relieve completely. UCSF neuroscientist Jennifer Mitchell, PhD, is testing a surprising brand-new approach that can ease symptoms of generalized anxiety disorder by reshaping how the brain thinks and feels.
